Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
3.94
Oct 30 • 3:59 PM ET Dollar change-0.14 Percentage change(-3.43%)
Aftermarket Close
3.94
Aftermarket • 7:54 PM ET Dollar change-0.00 Percentage change(-0.02%)
Category
US Equities - Factor & Thematic
Sponsor
Advisor Shares
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
0.78%
Inverse/Leveraged
IPO
Sep 02, 2020
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
-
Tags
-
Tags
-
Tags
-
Sector/Theme
Region
SMA20
-4.26%
SMA50
-14.69%
SMA200
-11.39%
Return% 1Y
-12.83%
Return% 3Y
-12.89%
Return% 5Y
-32.64%
Return% 10Y
Return% SI
Flows% 1M
-4.45%
Flows% 3M
-8.74%
Flows% YTD
-6.73%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
25
AUM
727.78M
NAV/sh
52W High
7.25 -45.66%
52W Low
2.96 33.11%
Volatility
3.98% 4.85%
ATR (14)
0.21
RSI (14)
37.96
Beta
1.52
Rel Volume
1.20
Avg Volume
4.71M
Volume
5,643,410
Perf Week
0.77%
Perf Month
-14.35%
Perf Quarter
-6.41%
Perf Half Y
-21.83%
Perf YTD
-16.53%
Perf Year
-8.37%
Perf 3Y
-22.29%
Perf 5Y
-85.46%
Perf 10Y
-
Prev Close
4.08
Price
3.94
Change %
-3.43%
AdvisorShares Pure US Cannabis ETF seeks long-term capital appreciation. The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.